Insider Selling: Atea Pharmaceuticals (NASDAQ:AVIR) Director Sells 6,741 Shares of Company Stock
MarketBeat
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR - Get Free Report) Director Bruno Lucidi sold 6,741 shares of the firm's stock in a transaction dated Tuesday, November 17th. The stock was sold at an average price of $4.03, for a total value of $27,166.23. Following the completion of the transaction, the director owned 157,237 shares of the company's stock, valued at approximately $633,665.11. The trade was a 4.11% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
NASDAQ:AVIR